BofA Securities Downgrades Beta Bionics, Inc. (BBNX) to Neutral 'on new patient starts miss'
Tweet Send to a Friend
BofA Securities analyst Travis Steed downgraded Beta Bionics, Inc. (NASDAQ: BBNX) from Buy to Neutral with a price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
